Reference Listed Drugs (RLD)

Reference Listed Drug Manufacturer, Supplier

A Reference Listed Drug (RLD) is an approved drug product to which new generic versions are compared to show that they are bioequivalent. A drug company seeking approval to market a generic equivalent must refer to the Reference Listed Drug in its Abbreviated New Drug Application (ANDA).

Our team possesses extensive expertise and a deep understanding of industry standards. We specialize in procuring both novel and branded drugs from major markets. With a robust network of partners worldwide, we consistently supply to prominent Indian companies from the US, UK, Europe, China, and SEA countries. Additionally, we offer transportation services for RLDs under optimal conditions and can facilitate customs clearance in India.

Presently, referencing a Reference Listed Drug (RLD) has evolved into a pivotal prerequisite for generic drug manufacturers during the filing of an Abbreviated New Drug Application (ANDA). An FDA-approved RLD plays a vital role in confirming the bioequivalence of an already sanctioned product. We distinguish ourselves as a premier service provider in RLD procurement, meticulously customized to meet distinct specifications.

For more details contact us at enquiry@sdasiapacific.com